Common dizziness drug class shows promise for treating vestibular migraine
A new study published in Otolaryngology–Head and Neck Surgery suggests that a class of medications called gepants may effectively treat vestibular migraine. These drugs, which block CGRP, offer an alternative for patients who cannot use injectable treatments.
Why it matters
Vestibular migraine is a common but underdiagnosed cause of vertigo; finding effective, non-injectable treatments could significantly improve quality of life for many patients.
edited by Gaby Clark , reviewed by Andrew Zinin
The article reports on medical research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in